Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentin

Journal of Biological Chemistry

Volumn 287, Issue 2, 2012, Pages 989-1006

  Bargagna Mohan, Paola ^a   Paranthan, Riya R ^b   Hamza, Adel ^c   Zhan, Chang Guo ^c   Lee, Do Min ^c   Kim, Kyung Bo ^c   Lau, Daniel L ^d   Srinivasan, Cidambi ^c   Nakayama, Keiko ^e   Nakayama, Keiichi I ^f   Herrmann, Harald ^g   Mohan, Royce ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; ENZYME INHIBITION; TISSUE REGENERATION;

CELL CULTURE MODELS; CYCLIN-DEPENDENT KINASE INHIBITORS; CYTOSKELETAL ELEMENTS; G2/M CELL CYCLE ARREST; INTERMEDIATE FILAMENTS; LIGAND-BINDING SITES; OVER-EXPRESSION; PHARMACOLOGICAL AGENTS;

MAMMALS;

ANTIFIBROTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1B; INTERMEDIATE FILAMENT PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; VIMENTIN; WITHAFERIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA FIBROSIS; CORNEA INJURY; CORNEA OPACITY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME REGULATION; G2 PHASE CELL CYCLE CHECKPOINT; HAZE; HUMAN; LIGAND BINDING; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TREATMENT DURATION; TREATMENT RESPONSE;

MUS;

EID: 84862939695     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.297150     Document Type: Article

References (89)

1. Whitcher, J. P., Srinivasan, M., and Upadhyay, M. P. (2001) Corneal blindness. A global perspective. Bull. World Health Organ. 79, 214-221
2. Salomao, M. Q., and Wilson, S. E. (2009) Corneal molecular and cellular biology update for the refractive surgeon. J. Refract. Surg. 25, 459-466
3. Taneri, S., Weisberg, M., and Azar, D. T. (2011) Surface ablation techniques. J. Cataract Refract. Surg. 37, 392-408
4. Qazi, Y., Wong, G., Monson, B., Stringham, J., and Ambati, B. K. (2010) Corneal transparency: genesis, maintenance and dysfunction. Brain Res. Bull. 81, 198-210
5. Schaffeld, M., Herrmann, H., Schultess, J., and Markl, J. (2001) Vimentin and desmin of a cartilaginous fish, the shark Scyliorhinus stellaris. Sequence, expression patterns and in vitro assembly. Eur. J. Cell Biol. 80, 692-702 (Pubitemid 34092937)
6. Herrmann, H., Bär, H., Kreplak, L., Strelkov, S. V., and Aebi, U. (2007) Intermediate filaments. From cell architecture to nanomechanics. Nat. Rev. Mol. Cell Biol. 8, 562-573 (Pubitemid 46985377)
7. Goldman, R. D., Grin, B., Mendez, M. G., and Kuczmarski, E. R. (2008) Intermediate filaments. Versatile building blocks of cell structure. Curr. Opin. Cell Biol. 20, 28-34
8. Helfand, B. T., Chang, L., and Goldman, R. D. (2004) Intermediate filaments are dynamic and motile elements of cellular architecture. J. Cell Sci. 117, 133-141 (Pubitemid 38128894)
9. Colucci-Guyon, E., Portier, M. M., Dunia, I., Paulin, D., Pournin, S., and Babinet, C. (1994) Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 79, 679-694 (Pubitemid 24363811)
10. Pekny, M. (2001) Astrocytic intermediate filaments. Lessons from GFAP and vimentin knock-out mice. Prog. Brain Res. 132, 23-30
11. Pekny, M., and Pekna, M. (2004) Astrocyte intermediate filaments in CNS pathologies and regeneration. J. Pathol. 204, 428-437 (Pubitemid 39468154)
12. Lundkvist, A., Reichenbach, A., Betsholtz, C., Carmeliet, P., Wolburg, H., and Pekny, M. (2004) Under stress, the absence of intermediate filaments from Müller cells in the retina has structural and functional consequences. J. Cell Sci. 117, 3481-3488 (Pubitemid 39206388)
13. Pekny, M., Johansson, C. B., Eliasson, C., Stakeberg, J., Wallén, A., Perlmann, T., Lendahl, U., Betsholtz, C., Berthold, C. H., and Frisén, J. (1999) Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J. Cell Biol. 145, 503-514 (Pubitemid 29215715)
14. Plodinec, M., Loparic, M., Suetterlin, R., Herrmann, H., Aebi, U., and Schoenenberger, C. A. (2011) The nanomechanical properties of rat fibroblasts are modulated by interfering with the vimentin intermediate filament system. J. Struct. Biol. 174, 476-484
15. Che, X., Chi, F., Wang, L., Jong, T. D., Wu, C. H., Wang, X., and Huang, S. H. (2011) Involvement of IbeA in meningitic Escherichia coli K1-induced polymorphonuclear leukocyte transmigration across brain endothelial cells. Brain Pathol. 21, 389-404
16. Bargagna-Mohan, P., Hamza, A., Kim, Y. E., Khuan, Abby Ho, Y., Mor-Vaknin, N., Wendschlag, N., Liu, J., Evans, R. M., Markovitz, D. M., Zhan, C. G., Kim, K. B., and Mohan, R. (2007) The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin. Chem. Biol. 14, 623-634 (Pubitemid 46920982)
17. Satelli, A., and Li, S. (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol. Life Sci. 68, 3033-3046
18. Verardo, M. R., Lewis, G. P., Takeda, M., Linberg, K. A., Byun, J., Luna, G., Wilhelmsson, U., Pekny, M., Chen, D. F., and Fisher, S. K. (2008) Abnormal reactivity of muller cells after retinal detachment in mice deficient in GFAP and vimentin. Invest. Ophthalmol. Vis. Sci. 49, 3659-3665
19. Eckes, B., Dogic, D., Colucci-Guyon, E., Wang, N., Maniotis, A., Ingber, D., Merckling, A., Langa, F., Aumailley, M., Delouvée, A., Koteliansky, V., Babinet, C., and Krieg, T. (1998) Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J. Cell Sci. 111, 1897-1907 (Pubitemid 28370534)
20. Eckes, B., Colucci-Guyon, E., Smola, H., Nodder, S., Babinet, C., Krieg, T., and Martin, P. (2000) Impaired wound healing in embryonic and adult mice lacking vimentin. J. Cell Sci. 113, 2455-2462 (Pubitemid 30601362)
21. Nieminen, M., Henttinen, T., Merinen, M., Marttila-Ichihara, F., Eriksson, J. E., and Jalkanen, S. (2006) Vimentin function in lymphocyte adhesion and transcellular migration. Nat. Cell Biol. 8, 156-162
22. Chaurasia, S. S., Kaur, H., de Medeiros, F. W., Smith, S. D., and Wilson, S. E. (2009) Dynamics of the expression of intermediate filaments vimentin and desmin during myofibroblast differentiation after corneal injury. Exp. Eye Res. 89, 133-139
23. Ishizaki, M., Zhu, G., Haseba, T., Shafer, S. S., and Kao, W. W. (1993) Expression of collagen I, smooth muscle α-actin, and vimentin during the healing of alkali-burned and lacerated corneas. Invest. Ophthalmol. Vis. Sci. 34, 3320-3328 (Pubitemid 23346664)
24. Mohan, R., Hammers, H. J., Bargagna-Mohan, P., Zhan, X. H., Herbstritt, C. J., Ruiz, A., Zhang, L., Hanson, A. D., Conner, B. P., Rougas, J., and Pribluda, V. S. (2004) Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7, 115-122 (Pubitemid 39491728)
25. Mishra, L. C., Singh, B. B., and Dagenais, S. (2000) Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha). A review. Altern. Med. Rev. 5, 334-346 (Pubitemid 30660827)
26. Bargagna-Mohan, P., Paranthan, R. R., Hamza, A., Dimova, N., Trucchi, B., Srinivasan, C., Elliott, G. I., Zhan, C. G., Lau, D. L., Zhu, H., Kasahara, K., Inagaki, M., Cambi, F., and Mohan, R. (2010) Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis. J. Biol. Chem. 285, 7657-7669
27. Paranthan, R. R., Bargagna-Mohan, P., Lau, D. L., and Mohan, R. (2011) Mol. Vision 17, 1901-1908
28. Lahat, G., Zhu, Q. S., Huang, K. L., Wang, S., Bolshakov, S., Liu, J., Torres, K., Langley, R. R., Lazar, A. J., Hung, M. C., and Lev, D. (2010) Vimentin is a novel anti-cancer therapeutic target. Insights from in vitro and in vivo mice xenograft studies. PLoS One 5, e10105
29. Yokota, Y., Bargagna-Mohan, P., Ravindranath, P. P., Kim, K. B., and Mohan, R. (2006) Development of withaferin A analogs as probes of angiogenesis. Bioorg. Med. Chem. Lett. 16, 2603-2607
30. Nakayama, K., Nagahama, H., Minamishima, Y. A., Matsumoto, M., Nakamichi, I., Kitagawa, K., Shirane, M., Tsunematsu, R., Tsukiyama, T., Ishida, N., Kitagawa, M., Nakayama, K., and Hatakeyama, S. (2000) Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication. EMBO J. 19, 2069-2081 (Pubitemid 30237582)
31. Cook, J. R., Mody, M. K., and Fini M. E. (1999) Failure to activate transcription factor NF-κB in corneal stromal cells (keratocytes). Invest. Ophthalmol. Vis. Sci. 40, 3122-3131
32. Herrmann, H., Häner, M., Brettel, M., Ku, N. O., and Aebi, U. (1999) Characterization of distinct early assembly units of different intermediate filament proteins. J. Mol. Biol. 286, 1403-1420 (Pubitemid 29121725)
33. Amano, S., Rohan, R., Kuroki, M., Tolentino, M., and Adamis, A. P. (1998) Requirement for vascular endothelial growth factor in wound- and inflammation- related corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 39, 18-22 (Pubitemid 28040457)
34. Falsey, R. R., Marron, M. T., Gunaherath, G. M., Shirahatti, N., Mahadevan, D., Gunatilaka, A. A., and Whitesell, L. (2006) Actin microfilament aggregation induced by withaferinAis mediated by annexin II. Nat. Chem. Biol. 2, 33-38
35. West-Mays, J. A., Cook, J. R., Sadow, P. M., Mullady, D. K., Bargagna- Mohan, P., Strissel, K. J., and Fini, M. E. (1999) Differential inhibition of collagenase and interleukin-1α gene expression in cultured corneal fibroblasts by TGF-β, dexamethasone, and retinoic acid. Invest. Ophthalmol. Vis. Sci. 40, 887-896 (Pubitemid 29153254)
36. Jester, J. V., Huang, J., Barry-Lane, P. A., Kao, W. W., Petroll, W. M., and Cavanagh, H. D. (1999) Transforming growth factor β-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest. Ophthalmol. Vis. Sci. 40, 1959-1967 (Pubitemid 29365158)
37. Tandon, A., Tovey, J. C., Sharma, A., Gupta, R., and Mohan, R. R. (2010) Role of transforming growth factor β in corneal function, biology, and pathology. Curr. Mol. Med. 10, 565-578
38. Stramer, B. M., Cook, J.R., Fini, M. E., Taylor, A., and Obin, M. (2001) Induction of the ubiquitin-proteasome pathway during the keratocyte transition to the repair fibroblast phenotype. Invest. Ophthalmol. Vis. Sci. 42, 1698-1706 (Pubitemid 32652342)
39. Saika, S., Miyamoto, T., Yamanaka, O., Kato, T., Ohnishi, Y., Flanders, K. C., Ikeda, K., Nakajima, Y., Kao, W. W., Sato, M., Muragaki, Y., and Ooshima, A. (2005) Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-κB, in treatment of corneal alkali burns in mice. Am. J. Pathol. 166, 1393-1403 (Pubitemid 40586510)
40. Bargagna-Mohan, P., Ravindranath, P. P., and Mohan, R. (2006) Small molecule antiangiogenic probes of the ubiquitin proteasome pathway. Potential application to choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 47, 4138-4145 (Pubitemid 46044333)
41. Oshima, T., Sonoda, K. H., Tsutsumi-Miyahara, C., Qiao, H., Hisatomi, T., Nakao, S., Hamano, S., Egashira, K., Charo, I. F., and Ishibashi, T. (2006) Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice. Br. J. Ophthalmol. 90, 218-222 (Pubitemid 43163855)
42. Ambati, B. K., Joussen, A. M., Kuziel, W. A., Adamis, A. P., and Ambati, J. (2003) Inhibition of corneal neovascularization by genetic ablation of CCR2. Cornea 22, 465-467 (Pubitemid 36759041)
43. Nakazawa, T., Takeda, M., Lewis, G. P., Cho, K. S., Jiao, J., Wilhelmsson, U., Fisher, S. K., Pekny, M., Chen, D. F., and Miller, J. W. (2007) Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin. Invest. Ophthalmol. Vis. Sci. 48, 2760-2768 (Pubitemid 351261231)
44. Yoshida, K., Nakayama, K., Nagahama, H., Harada, T., Harada, C., Imaki, J., Matsuda, A., Yamamoto, K., Ito, M., Ohno, S., and Nakayama, K. (2002) Involvement of p27KIP1 degradation by Skp2 in the regulation of proliferation in response to wounding of corneal epithelium. Invest. Ophthalmol. Vis. Sci. 43, 364-370 (Pubitemid 34113216)
45. Zieske, J. D. (2000) Expression of cyclin-dependent kinase inhibitors during corneal wound repair. Prog. Retin. Eye Res. 19, 257-270
46. Kase, S., Yoshida, K., Ohgami, K., Shiratori, K., Ohno, S., and Nakayama, K. I. (2006) Phosphorylation of p27KIP1 in the mitotic cells of the corneal epithelium. Curr. Eye Res. 31, 307-312
47. Nakayama, K., Nagahama, H., Minamishima, Y. A., Miyake, S., Ishida, N., Hatakeyama, S., Kitagawa, M., Iemura, S., Natsume, T., and Nakayama, K. I. (2004) Skp2-mediated degradation of p27 regulates progression into mitosis. Dev. Cell 6, 661-672 (Pubitemid 38579350)
48. Herrmann, H., and Aebi, U. (2004) Intermediate filaments. Molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu. Rev. Biochem. 73, 749-789 (Pubitemid 39050385)
49. Mackey, D. A., Wilkinson, C. H., Kearns, L. S., and Hewitt, A. W. (2011) Classification of iris colour. Review and refinement of a classification schema. Clin. Experiment. Ophthalmol. 39, 462-471
50. Conway, B. R., Chatterjee, S., Field, G. D., Horwitz, G. D., Johnson, E. N., Koida, K., and Mancuso, K. (2010) Advances in color science. From retina to behavior. J. Neurosci. 30, 14955-14963
51. Dyer, M. A., and Cepko, C. L. (2000) Control of Müller glial cell proliferation and activation following retinal injury. Nat. Neurosci. 3, 873-880
52. Vij, N., Roberts, L., Joyce, S., and Chakravarti, S. (2004) Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis. Implications in the cornea. Exp. Eye Res. 78, 957-971 (Pubitemid 38402204)
53. Yoon, M., Moir, R. D., Prahlad, V., and Goldman, R. D. (1998) Motile properties of vimentin intermediate filament networks in living cells. J. Cell Biol. 143, 147-157 (Pubitemid 28480524)
54. Soellner, P., Quinlan, R. A., and Franke, W. W. (1985) Identification of a distinct soluble subunit of an intermediate filament protein. Tetrameric vimentin from living cells. Proc. Natl. Acad. Sci. U.S.A. 82, 7929-7933 (Pubitemid 16169469)
55. Chou, Y. H., Flitney, F. W., Chang, L., Mendez, M., Grin, B., and Goldman, R. D. (2007) The motility and dynamic properties of intermediate filaments and their constituent proteins. Exp. Cell Res. 313, 2236-2243 (Pubitemid 46842986)
56. Moon, R. T., and Lazarides, E. (1983) Synthesis and post-translational assembly of intermediate filaments in avian erythroid cells. Vimentin assembly limits the rate of synemin assembly. Proc. Natl. Acad. Sci. U.S.A. 80, 5495-5499 (Pubitemid 14242875)
57. Skalli, O., Chou, Y. H., and Goldman, R. D. (1992) Cell cycle-dependent changes in the organization of an intermediate filament-associated protein. Correlation with phosphorylation by p34cdc2. Proc. Natl. Acad. Sci. U.S.A. 89, 11959-11963 (Pubitemid 23004764)
58. Franke, W. W., Schmid, E., Grund, C., and Geiger, B. (1982) Intermediate filament proteins in nonfilamentous structures. Transient disintegration and inclusion of subunit proteins in granular aggregates. Cell 30, 103-113 (Pubitemid 13237089)
59. Chang, H. C., Chang, F. R., Wang, Y. C., Pan, M. R., Hung, W. C., and Wu, Y. C. (2007) A bioactive withanolide Tubocapsanolide A inhibits proliferation of human lung cancer cells via repressing Skp2 expression. Mol. Cancer Ther. 6, 1572-1578
60. Hara, T., Kamura, T., Nakayama, K., Oshikawa, K., Hatakeyama, S. (2001) Degradation of p27Kip1 at the G0-G1 transition mediated by a Skp2-independent ubiquitination pathway. J. Biol. Chem. 276, 48937-48943
61. Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., and Hershko, A. (2003) Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J. Biol. Chem. 278, 25752-25757 (Pubitemid 36835332)
62. Bond, M., and Wu, Y. J. (2011) Proliferation unleashed. The role of Skp2 in vascular smooth muscle cell proliferation. Front. Biosci. 16, 1517-1535
63. Amador, V., Ge, S., Santamaría, P. G., Guardavaccaro, D., and Pagano, M. (2007) APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol. Cell 27, 462-473 (Pubitemid 47126938)
64. Stan, S. D., Zeng, Y., and Singh, S. V. (2008) Nutr. Cancer 60, Suppl. 1, 51-60
65. Hu, D., Liu, W., Wu, G., and Wan, Y. (2011) Nuclear translocation of Skp2 facilitates its destruction in response to TGFβ signaling. Cell Cycle 10, 285-292
66. Jiang, X., Austin, P. F., Niederhoff, R. A., Manson, S. R., Riehm, J. J., Cook, B. L., Pengue, G., Chitaley, K., Nakayama, K., Nakayama, K. I., and Weintraub, S. J. (2009) Mechanoregulation of proliferation. Mol. Cell Biol. 29, 5104-5114
67. Wang, F., Qi, L. X., Su, Y., Yan, Q. H., and Teng, Y. (2010) Inhibition of cell proliferation of Tenon's capsule fibroblast by S-phase kinase-interacting protein 2 targeting SiRNA through increasing p27 protein level. Invest. Ophthalmol. Vis. Sci. 51, 1475-1482
68. Suzuki, S., Fukasawa, H., Kitagawa, K., Uchida, C., Hattori, T., Isobe, T., Oda, T., Misaki, T., Ohashi, N., Nakayama, K., Nakayama, K. I., Hishida, A., Yamamoto, T., and Kitagawa, M. (2007) Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice. Am. J. Pathol. 171, 473-483 (Pubitemid 47344680)
69. Ishizaki, M., Wakamatsu, K., Matsunami, T., Yamanaka, N., Saiga, T., Shimizu, Y., Zhu, G., and Kao, W. W. (1994) Dynamics of the expression of cytoskeleton components and adherens molecules by fibroblastic cells in alkali-burned and lacerated corneas. Exp. Eye Res. 59, 537-549 (Pubitemid 24359873)
70. Dupps, W. J., Jr., and Wilson, S. E. (2006) Biomechanics and wound healing in the cornea. Exp. Eye Res. 83, 709-720
71. Schopferer, M., Bär, H., Hochstein, B., Sharma, S., Mücke, N., Herrmann, H., and Willenbacher, N. (2009) Desmin and vimentin intermediate filament networks. Their viscoelastic properties investigated by mechanical rheometry. J. Mol. Biol. 388, 133-143
72. Tanter, M., Touboul, D., Gennisson, J. L., Bercoff, J., and Fink, M. (2009) High-resolution quantitative imaging of cornea elasticity using supersonic shear imaging. IEEE Trans. Med. Imaging 28, 1881-1893
73. Macsai, M. S. (2000) The management of corneal trauma. Advances in the past twenty-five years. Cornea 19, 617-624
74. Müller, L. J., Pels, E., and Vrensen, G. F. (2001) The specific architecture of the anterior stroma accounts for maintenance of corneal curvature. Br. J. Ophthalmol. 85, 437-443 (Pubitemid 32275625)
75. Lacolley, P., Challande, P., Boumaza, S., Cohuet, G., Laurent, S., Boutouyrie, P., Grimaud, J. A., Paulin, D., Lamazière, J. M., and Li, Z. (2001) Mechanical properties and structure of carotid arteries in mice lacking desmin. Cardiovasc. Res. 51, 178-187 (Pubitemid 32523067)
76. Scott, R. S., Li, Z., Paulin, D., Uvelius, B., Small, J. V., and Arner, A. (2008) Role of desmin in active force transmission and maintenance of structure during growth of urinary bladder. Am. J. Physiol. Cell Physiol. 295, C324-C331 (Pubitemid 352755769)
77. Saika, S., Ikeda, K., Yamanaka, O., Flanders, K. C., Nakajima, Y., Miyamoto, T., Ohnishi, Y., Kao, W. W., Muragaki, Y., and Ooshima, A. (2005) Therapeutic effects of adenoviral gene transfer of bone morphogenic protein- 7 on a corneal alkali injury model in mice. Lab. Invest. 85, 474-486 (Pubitemid 40523940)
78. Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., and Brown, R. A. (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3, 349-363 (Pubitemid 34619269)
79. Petroll, W. M., Vishwanath, M., and Ma, L. (2004) Corneal fibroblasts respond rapidly to changes in local mechanical stress. Invest. Ophthalmol. Vis. Sci 45, 3466-3474 (Pubitemid 39298564)
80. Hassell, J. R., and Birk, D. E. (2010) The molecular basis of corneal transparency. Exp. Eye Res. 91, 326-335
81. Zhao, X. H., Laschinger, C., Arora, P., Szászi, K., Kapus, A., McCulloch, C. A. (2007) Force activates smooth muscle α-actin promoter activity through the Rho signaling pathway. J. Cell Sci. 120, 1801-1809 (Pubitemid 46930418)
82. Lu, Y. B., Iandiev, I., Hollborn, M., Körber, N., Ulbricht, E., Hirrlinger, P. G., Pannicke, T., Wei, E. Q., Bringmann, A., Wolburg, H., Wilhelmsson, U., Pekny, M., Wiedemann, P., Reichenbach, A., and Käs, J. A. (2011) Reactive glial cells: increased stiffness correlates with increased intermediate filament expression. FASEB J. 25, 624-631
83. Jester, J. V., Petroll, W. M., and Cavanagh, H. D. (1999) Corneal stromal wound healing in refractive surgery. The role of myofibroblasts. Prog. Retin. Eye Res. 18, 311-356 (Pubitemid 29092610)
84. Rogel, M. R., Soni, P. N., Troken, J. R., Sitikov, A., Trejo, H. E., and Ridge, K. M. (2011) Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells. FASEB J. 25, 3873-3883
85. Hopkinson-Woolley, J., Hughes, D., Gordon, S., Martin, P. (1994) Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J. Cell Sci. 107, 1159-1167 (Pubitemid 24177317)
86. Müller, M., Bhattacharya, S. S., Moore, T., Prescott, Q., Wedig, T., Herrmann, H., and Magin, T. M. (2009) Dominant cataract formation in association with a vimentin assembly disrupting mutation. Hum. Mol. Genet. 18, 1052-1057
87. Bär, H., Mücke, N., Ringler, P., Müller, S. A., Kreplak, L., Katus, H. A., Aebi, U., and Herrmann, H. (2006) Impact of disease mutations on the desmin filament assembly process. J. Mol. Biol. 360, 1031-1042 (Pubitemid 44062518)
88. Thaiparambil, J. T., Bender, L., Ganesh, T., Kline, E., Patel, P., Liu, Y., Tighiouart, M., Vertino, P. M., Harvey, R. D., Garcia, A., and Marcus, A. I. (2011) Withaferin A inhibits breast cancer invasion and metastasis at subcytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int. J. Cancer 129, 2744-2755
89. Maxwell, S. A., Cherry, E. M., and Bayless, K. J. (2011) Akt, 14-3-3ζ, and vimentin mediate a drug-resistant invasive phenotype in diffuse large Bcell lymphoma. Leuk. Lymphoma 52, 849-864